Search Results - "Mitchell, Aaron C"
-
1
Engineering growth factors for regenerative medicine applications
Published in Acta biomaterialia (01-01-2016)“…[Display omitted] Growth factors are important morphogenetic proteins that instruct cell behavior and guide tissue repair and renewal. Although their…”
Get full text
Journal Article -
2
A novel protein‐engineered hepatocyte growth factor analog released via a shear‐thinning injectable hydrogel enhances post‐infarction ventricular function
Published in Biotechnology and bioengineering (01-10-2017)“…ABSTRACT In the last decade, numerous growth factors and biomaterials have been explored for the treatment of myocardial infarction (MI). While pre‐clinical…”
Get full text
Journal Article -
3
Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein
Published in The Journal of biological chemistry (06-04-2018)“…Dysregulated matriptase activity has been established as a key contributor to cancer progression through its activation of growth factors, including the…”
Get full text
Journal Article -
4
Development of a Protease Biosensor Based on a Dimerization-Dependent Red Fluorescent Protein
Published in ACS chemical biology (19-01-2018)“…Dysregulated activity of the protease matriptase is a key contributor to aggressive tumor growth, cancer metastasis, and osteoarthritis. Methods for the…”
Get full text
Journal Article -
5
Degradable Acetalated Dextran Microparticles for Tunable Release of an Engineered Hepatocyte Growth Factor Fragment
Published in ACS biomaterials science & engineering (08-02-2016)“…Injectable biomaterials are promising as new therapies to treat myocardial infarction (MI). One useful property of biomaterials is the ability to protect and…”
Get full text
Journal Article -
6
Abstract 20275: A Novel Engineered Hepatocyte Growth Factor Analog Released via a Temperature-Responsive, Shear-Thinning Hydrogel Enhances Post-Infarction Ventricular Function
Published in Circulation (New York, N.Y.) (11-11-2016)“…ObjectiveHepatocyte growth factor is cardioprotective, anti-apoptotic, and pro-angiogenic; yet, is limited in clinical translation due to its high…”
Get full text
Journal Article